ALFA News
Straight from the exchange filing
Every announcement Natco Pharma has filed with the exchanges that we have reported, newest first. Each story links the original filing.
Every Natco Pharma announcement on ALFA FilingsSee filings →Reference market data from a third-party provider, as of the most recent story. Not a valuation or a recommendation.
Natco Pharma launches Carboplatin Injection, a generic Paraplatin®, in the U.S. market to address critical shortages. Market size estimated at USD 27.8 million.
Natco Pharma approves a ₹1,300 crore rights issue for equity shareholders and provides a key update on its demerger with Natco Crop Health Sciences Limited.
